ALEXIS EDMUNDS: Open Payments
NPI 1538826250 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 8 payments from 5 companies in 2025. Trend: 2023 $109 · 2024 $244 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $110 |
| MILLICENT US INC | 3 | $63 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| Organon LLC | 1 | $29 |
| Exeltis, USA Inc. | 1 | $17 |
Products named: JOURNAVX, MYFEMBREE, FEMLYV, NEXPLANON, INTRAROSA, SLYND.
Industry payments across TX — which companies pay providers there.
